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Abstract 
Background: This is the first study to investigate spermatozoal cell death-inducing DNA fragmentation factor-α-like 
effector A (CIDEA) gene expression and DNA fragmentations in the spermatozoa of men diagnosed with metabolic 
syndrome (MS) who have normal seminograms with unexplained infertility, and to correlate these parameters with 
seminal glucose concentration.
Methods: This study included 120 participants: 75 male subjects with MS (38 fertile and 37 infertile), and a control 
group of 45 fertile males without MS. HOMA-IR, semen analysis, and biochemical measurement of seminal plasma 
insulin and glucose levels were carried out. Spermatozoal insulin gene and CIDEA gene expressions were performed 
by the RT-PCR method. The percentage of spermatozoal DNA fragmentation was also estimated.
Results: The spermatozoal insulin and CIDEA gene expression, as well as the DNA fragmentation, were significantly 
higher in the infertile MS group than in the fertile MS group, and significantly higher in both the MS groups than in 
the control group. Seminal glucose concentration showed significant positive correlations with seminal insulin level, 
spermatozoa insulin, CIDEA gene expression, and DNA fragmentation. Moreover, there was a positive correlation 
between spermatozoa CIDEA gene expression and DNA fragmentation.
Conclusions: It can be concluded that MS may affect male fertility at the molecular level, through its possible induc-
ing effect of spermatozoa CIDEA and insulin gene expression, DNA fragmentation, and increased seminal glucose.
Keywords: CIDEA, Insulin genes expression, DNA fragmentation, Seminal glucose, Male infertility, Metabolic 
syndrome
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Background
Infertility is defined by the World Health Organization 
(WHO) as “the inability of a couple to achieve concep-
tion or bring a pregnancy to term after 12  months or 
more of regular, unprotected sexual intercourse” [1]. 
Infertility affects up to 15% of couples. A male factor is 
solely responsible in about 20% of infertile couples and 
contributory in 30–40% of cases [2]. Metabolic syndrome 
(MS) or syndrome of insulin resistance is a multi-factorial 
endocrinopathy that is framed by classical cardiovascular 
risk factors, including insulin resistance, hyperglycemia, 
abdominal obesity, a pro-inflammatory state, essen-
tial hypertension, and dyslipidemia. The frequency of 
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important reason for the mortality and morbidity caused 
by cardiovascular diseases [3].
A possible association between MS and male infertility 
has been hypothesized [4]. Du Plessis et al. [5] postulated 
that male obesity and MS are associated with hypog-
onadism. Leisegang et  al. [6] reported that insulin and 
leptin, which are important regulators of male reproduc-
tion via modulation of the hypothalamus-pituitary-testes 
(HPT) axis, were detected in the seminal fluid of obese 
infertile men. They suggested that both hormones could 
be synthesized and secreted by ejaculated spermatozoa 
through apparent autocrine regulatory functions.
Glucose was also detected in human semen, and it 
represented about half of the sugar consumed by the 
ejaculated spermatozoa [7]. Oxidative stress is known to 
play an important role in various manifestations of MS. 
Hyperglycemia causes oxidative stress and accelerates the 
accumulation of advanced glycation end products (AGEs) 
in the male genital tract, products which are capable of 
producing, endorsing, and/or increasing oxidative stress 
and of inducing sperm nuclear DNA (nDNA) damage [8]. 
Sperm nDNA damage may be present in men with normal 
or abnormal semen parameters [9]. As significant DNA 
fragmentation can be present in normozoospermic sub-
fertile men, it may be an important factor in unexplained 
infertility that appears in approximately 15–30% of infer-
tile couples [10]. The need to introduce the evaluation 
of sperm DNA quality into the clinical setting has been 
acknowledged [11]; however, it is not routinely assessed in 
semen analysis according to WHO guidelines [1].
Cell death-inducing DNA fragmentation factor-α-like 
effector A (CIDEA) belongs to the CIDE family of proa-
poptotic proteins [12]. It has a role in lipid metabolism, 
body weight regulation, and the development of meta-
bolic disorders [13]. In humans, the CIDEA gene is pre-
dominantly expressed in white fat cells and inhibits 
adipocyte lipolysis [14]. It is the most up-regulated gene 
in human white adipose tissue, following dietary weight 
reduction [15]. CIDEA transcripts of various lengths are 
present in different human tissues (e.g., heart, skeletal 
muscle, brain, placenta, white adipose tissue, and kidney) 
[12], but there are no reports about CIDEA expression by 
human spermatozoa.
Based on a search of the scientific literature, it is appar-
ent that the effect of MS on male (in)fertility has not 
been sufficiently investigated. Therefore, with reference 
to the impact of MS on male (in)fertility, this study aims 
to investigate spermatozoa DNA fragmentation, CIDEA, 
and insulin gene expressions in men diagnosed with MS 
and unexplained delayed fertility, in spite of normal semi-
nograms. It also aims to correlate these variables with 
seminal glucose concentration, in an attempt to find a 
possible pathophysiologic mechanism in such subjects.
Methods
Selection of subjects
The study was carried out on 120 participants: 38 fer-
tile men with already diagnosed MS, 37 infertile men 
with already diagnosed MS, and 45 age-matched fertile 
volunteers as a control group. The fertile volunteers 
had offspring during the first year of their respective 
marriages, and they did not meet the criteria of MS. 
They were healthy, fertile persons personally known 
to us, and we explained the idea of the study to them 
by personal communication. When they were asked to 
participate they accepted and signed informed consent 
forms.
The fertile men with MS were referred to the Androl-
ogy Unit from the obesity clinic at Mansoura University 
Hospital, and they were considered fertile because all of 
them had offspring during the first year of their respec-
tive marriages. They were referred to the Andrology 
Unit as they were already MS patients, and their doctors 
needed to check the maintenance of their fertility status 
given the continuation of MS. The infertile subjects had 
normal seminograms according to WHO [1]. Patients 
represented a consecutive series of men attending the 
Andrology Unit at Mansoura University Hospital, from 
January 2013 to July 2014. All of them had been mar-
ried for ≥1 year with failed conception in spite of regu-
lar unprotected intercourse. Members of infertile couples 
whose infertility had female factors were excluded. A 
complete detailed infertility sheet was reviewed with 
each participant. Complete general and local genital 
examinations, including digital rectal examinations, were 
carried out. The selected men had normal serum levels of 
FSH, LH, testosterone (total and free), estradiol, prolac-
tin, and thyroid hormones.
This study excluded any patient with abnormal semen 
parameters, including leukocytospermia (>1  ×  106/ml), 
or with obvious infertility risk factors detected from the 
history, e.g. exposure to gonadotoxins, cigarette smok-
ing, recreational drug use, alcohol consumption, surgery 
for varicocele, undescended testis, urogenital infec-
tions. Likewise, infertility risk factors detected during an 
examination, such as small sized testes, varicocele, and 
cryptorchidism were exclusion factors. In addition, any 
patient with any medical problem other than MS such as 
tuberculosis, heart disease, renal disease, autoimmune 
disorders, cancer, liver diseases, endocrine disorders e.g. 
Cushing disease, known or clinically detected acute or 
chronic inflammatory conditions not related to MS, or 
long-term medication such as corticosteroids, was also 
excluded from the study. Color Doppler ultrasounds 
(CDU) were carried out to detect subclinical varicocele, 
and affected patients were excluded in addition to those 
with palpable varicocele.
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Based on the clinical and laboratory data, a diagnosis 
of MS was made according to the diagnostic criteria out-
lined by Alberti et  al. [16]. A minimum of three of the 
following five criteria need to be fulfilled to obtain a diag-
nosis of MS:
1. Waist circumference in Middle East and Mediterra-
nean men of ≥94 cm.
2. Blood pressure: systolic  ≥130  mmHg and/or dias-
tolic ≥85 mmHg (or antihypertensive medication).
3. Fasting triglycerides ≥1.69  mmol/l (≥150  mg/dl) or 
relevant medication.
4. Fasting HDL cholesterol  <1.00  mmol/l in males 
(<40 mg/dl) or relevant medication.
5. Fasting glucose >5.5 mmol/l (≥110 mg/dl).
Samples collection
Five millilitre fasting blood samples were withdrawn on 
K2EDTA and centrifuged at 7000  rpm to prepare the 
plasma for measurement of fasting plasma glucose and 
insulin, for calculation using the homeostasis model 
assessment of insulin resistance (HOMA-IR). One semen 
sample was collected from each participant in the Infer-
tility Clinic of the Andrology Unit at Mansoura Uni-
versity Hospital, and referred to the laboratory of the 
Medical Biochemistry Department, Faculty of Medicine, 
Mansoura University. All semen samples were collected 
by masturbation after an ejaculatory abstinence period of 
3–5 days.
Standard semen analysis
The sample was collected into a graduated glass meas-
uring cylinder with a wide mouth. The volume was read 
directly from the graduations. Seminal fluid was left for 
60 min at 37 °C to liquefy. After liquefaction, the sperm 
count and motility (progressive and total) was assessed 
using the Motility/Concentration module of the com-
puter assisted semen analysis (CASA) system using 
MiraLab—Egypt (Mira 9000 Sperm Analyzer CASA soft-
ware). For analysis, a Trinoculer Microscope with a plain 
objective lens (Olympus), equipped with phase contrast 
optics and a heated stage (37 °C), was used.
Morphology was assessed by the preparation of a 
smear and the application of the spermMac stain stain-
ing method (Fertipro, Belgium) as outlined by the WHO 
[1]. Leukocyte concentration was determined using 
the peroxidase staining technique according to that of 
Politch and colleagues [17] and first described by Endtz 
[18]. Viability was assessed using an Eosin Y stain. A 
blinded observer scored 100 cells for stain uptake (dead 
cells) or exclusion (live cells) [19, 20]. Seminal plasma 
was obtained by subjecting the semen samples after 
liquefaction to centrifugation at 7000  rpm. The super-
natant fluid was separated into aliquots and stored at 
−30 °C until used to estimate the seminal plasma glucose 
and insulin levels.
CIDEA and insulin genes expression
RNA extraction
After liquefaction, one ml of each collected sample was 
taken into tubes containing two ml of RNA later solution 
(Sigma). Spermatozoa were precipitated by centrifuga-
tion (7000  rpm, 10  min, 4  °C), and washed three times 
by phosphate buffered saline (PBS) to obtain a cell free 
sperm pellet. Total RNA extraction was carried out from 
the sperm pellet using TriFast TM reagent (PeqLab. Bio-
technologie GmbH, Carl-Thiersch St. 2B 91052 Erlongen, 
Germany, Cat. No. 30-2010) according to the manufac-
turer’s instructions. The remaining DNA was removed 
by digestion with DNase I (Sigma). The concentration of 
isolated RNA was determined spectrophotometrically by 
measuring the optical density (OD) at 260  nm (Jenway, 
Genova Model, UK). Ten microlitre of each sample was 
added to 990 µl of Diethyl pyrcarbonate (DEPC) treated 
water, and quantified by measuring the absorbance at 
260 nm as RNA yield (µg/ml) = A260 × 40 × 100 (dilu-
tion factor) [21]. The purity of the RNA was determined 
by gel electrophoresis using formaldehyde agarose gel 
electrophoresis and ethidium bromide staining to show 
two sharp bands, representing 28S and 18S ribosomal 
RNA.
Reverse transcriptase and synthesis of cDNA
First strand cDNA synthesis from the total RNA was per-
formed using QIAGEN LongRange 2 Step RT-PCR Kit 
(100) (Germany-Cat. No. 205922): 20 μl reaction mix was 
prepared by addition of 2 μl of template-extracted RNA 
from the sperm pellet and 9.8 μl DEPC treated water to 
a reverse-transcription master mix that contained 4  μl 
LongRange RT Buffer, 5×, 2 μl dNTP mix (10 mM each), 
1 μl Oligo-dT (20 μM), 0.2 μl longrange RNase inhibitor 
(4 U/μl), and 1  μl longrange reverse transcriptase. The 
protocol for reverse transcriptase and cDNA synthesis 
was carried out according to the manufacturer’s instruc-
tions by mixing the master mix thoroughly and carefully 
by vortexing for 5 s, incubating for 50 min at 42 °C, then 
inactivating the enzyme by heating at 85  °C for 15 min. 
The synthesized cDNA was stored at −80  °C until uti-
lized for semi-quantitative insulin gene and quantitative 
CIDEA gene expression, respectively.
Semiquantitative RT‑PCR for insulin gene expression
Amplification and detection Gene-specific primers were 
purchased from biosearch technologies (CA 94954-6904 
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USA); insulin: forward, 5′-GCC TTT GTG AAC CAA 
CAC CTG-3′; and reverse, 5′-GTT GCA GTA GTT 
CTC CAG CTG-3′ (261  bp fragment) [20]. The mRNA 
of β-actin was used as an endogenous external control 
for RT-PCR: Primers for β-actin to generate a (218  bp) 
fragment were designed as sense primers, 5′-AAGA-
GAGGCATCCTCACCCT-3′ and antisense primers, 
5′-TACATGGCTGGGGTGTTGAA-3′ [22].
For insulin, the conditions for PCR described by Aquila 
et al. [20] were followed: denaturation at 95 °C for 1 min, 
annealing at 62  °C for 1 min, and extension at 72  °C for 
2  min (40 cycles) and at 72  °C for 7  min for the final 
extension. For β actin the conditions were 32 cycles of 
denaturation at 95 °C for 1 min, annealing at 60 °C, 58 °C 
for 1 min, and an extension at 72 °C for 1 min, then a final 
extension at 72  °C for 10  min. Amplification was per-
formed in a thermal cycler (TECHEN TC-312, Model 
FTC3102D, Barloworld Scientific Ltd. Stone, Stafford 
Shire St 150 SA, UK).
The PCR products were analyzed by electrophoresis 
and ethidium bromide staining at 1% for insulin, visu-
alized via a light UV Transilluminator (Model TUV-20, 
OWI Scientific, Inc. 800 242-5560, France), and photo-
graphed under fixed conditions (the distance, the light, 
and the zoom). The resulting photos were analyzed with 
Scion Image® release Alpha 4.0.3.2. Software for Win-
dows®, which performs band detection and conversion 
to peaks. The areas under each peak were calculated in 
square pixels and used for quantification. Gene expres-
sion levels were determined by calculating the ratio 
between the square pixel values of the target gene in rela-
tion to the internal housekeeping control gene (β actin), 
minus RT the controls permitted to rule out genomic 
contamination. Similarly, no products were detected 
when the RT-PCR step was carried out with no added 
RNA, indicating that all reagents were free of target 
sequence contamination.
Real time RT‑PCR for CIDEA gene expression
Gene‑specific PCR primers Primers of CIDEA for 
real time RT-PCR according to Yu et  al. were used [23]: 
CIDEA; Forward: CATGTATGAGATGTACTCCGTGTC, 
Reverse: GAGTAGGACAGGAACCGCAG (Gene Bank 
number NM_001279.3) (PCR product: 90 bp); for β-actin, 
used as internal control, they were 5′-AGGCCAAC-
CGCGAGAAGATGACC-3′ (forward) and 5′-GAAGTC-
CAGGGCGACGTAGCAC-3′ (reverse); β-actin PCR 
product: 332 bp) (Gene Bank-Actin beta [NM_001101.3]) 
[24]. The gene-specific primers were purchased from 
Oligo™ Macrogen. The primer concentration is optimized 
for use in real-time PCR to determine the minimum primer 
concentration giving the lowest CT (threshold cycle) and 
minimizing nonspecific amplification.
Quantitative real‑time PCR The real-time PCR assays 
were performed with real-time PCR (Applied Biosystem 
7500, USA) with 96-well plates, using a SybrGreen rea-
gent [SYBR® Green PCR Master Mix (Applied Biosystem, 
USA, Cat. No. 4344463)]. Reactions were performed in 
duplicates; each reaction (25  μl) contains forward and 
reverse primers (10 pmol), a 12.5 μl Power Sybr® Green 
PCR master mix reaction buffer (Applied Biosystems), 
and 2  μl cDNA. The cycling parameters were 95  °C for 
30 s, 60 °C for 1 min, and 40 cycles after an initial step of 
95  °C for 10  min. The CT (cycle threshold) values were 
calculated. Melting curve analysis and agarose gel electro-
phoresis 2% were used to confirm the specificity of the 
PCR products. A reaction with no template was used as a 
negative control in each experiment.
The relative quantification of the CIDEA gene in differ-
ent samples was calculated by a comparative method. β 
actin was used as an endogenous control. Each analysis 
was done with 4 reactions (2 for the target gene, CIDEA, 
and 2 for analysis of the internal control, β actin). The 
ΔCT for each sample was calculated, and finally the 
ΔΔCT between MS and control samples was calculated 
and linearized using 2−ΔΔCt for overall change.
DNA fragmentation analysis using comet assay
A modified alkaline Comet assay for sperm was carried 
out on the prepared samples according to the method of 
Hughes et al. [25]. Fully frosted slides were covered with 
100  ml of 0.5% normal melting point agarose, and the 
agarose was allowed to solidify. Sperm in BWW (10 μl) 
were mixed with 90  μl of 0.5% low melting point aga-
rose that was used to form the second layer. Then, the 
slides were placed in a lysis buffer for 1 h (2.5 M NaCl, 
100 mMNaEDTA, 10 mMTris, 1% Triton X-100, and 
10% dimethyl sulphoxide, pH 10). The slides were incu-
bated overnight at 37  °C in 100  ml/ml proteinase K 
that had been added to the lysis buffer. Then, the slides 
were placed in a horizontal electrophoresis unit filled 
with fresh alkaline electrophoresis solution containing 
300  mMNaOH and 1  mM EDTA, pH 12.5, for 20  min, 
to allow unwinding of the DNA in the cells. Electropho-
resis was performed for 10 min at room temperature, at 
2 V (0.714 V/cm) and 300 mA, obtained by adjusting the 
buffer level. The slides were then washed with a neutral-
izing solution of 0.4 M Tris, pH 7, to remove alkali and 
detergents. After neutralization, the slides were stained 
with ethidium bromide (20  mg/ml) and covered with a 
cover-slip. All steps were carried out under yellow light 
to prevent further DNA damage.
Each slide was examined under a 20×  objective of a 
fluorescence microscope equipped with an excitation 
filter of 565 nm and a barrier filter of 590 nm. A digital 
camera was attached to the microscope, and images of 
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the cells were processed by a computer-assisted image-
analysis system (Comet Score, TriTek, USA) to deter-
mine the comet parameters. Fifty cells were scored 
from each replicate slide (100 cells in total). Results 
were expressed as tail length (TL; the distance that the 
DNA migrated) and also percentage of DNA in tail (% 
Tail; the density of the migrated DNA), one of the most 
reliable measurements for detecting DNA damage 
and tail moment (TM) (tail length ×  tail percentage of 
DNA/100).
Homeostasis model assessment of insulin resistance 
(HOMA‑IR)
In each sample, the degree of insulin resistance was esti-
mated by the HOMA-IR as described by Matthews et al. 
[26]. HOMA-IR was calculated by taking into account 
the fasting insulin and blood glucose levels accord-
ing to the equation (HOMA-IR) =  fasting insulin (μU/
ml)  ×  fasting plasma glucose (mg/dl)  ×  0.0551/22.5. 
Serum and seminal insulin levels were estimated using 
the ELISA Kit [27]. The kit was provided by Diagnostic 
Systems Laboratories. Inc. Corporate Headquarters, 445 
Medical Center Blvd., Webster, Texas 77598-4217. Semi-
nal and fasting blood glucose levels were measured col-
orimetrically [7].
Statistical analysis
Data are expressed as mean value ± SD. Comparisons are 
carried out by analysis of variance followed by Tukey’s 
test, using SPSS for Windows (17.0 Version). For statisti-
cal comparison between different groups, the significance 
of difference is tested using an ANOVA (analysis of vari-
ance) to compare results between more than two groups 
of numerical data. A Pearson correlation is used to assess 
relations between variables. Differences are considered 
statistically significant when P < 0.05.
Results
Ages, some metabolic parameters, different semen 
parameters, and genetic studies of subjects and controls 
are supplied in Table 1. Spermatozoa insulin and CIDEA 
genes expression were significantly increased in the infer-
tile MS group compared to the fertile MS group, and 
both were significantly higher than in the control group 
(Table 1; Figs. 1, 2).
Spermatozoa nDNA fragmentation, detected quantita-
tively by the Comet assay technique, shows a higher per-
centage in the infertile MS group than in the fertile MS 
group, and both MS groups are significantly higher than 
the control group. In addition, qualitative assessment of 
the degree of DNA fragmentation shows a similar result; 
these parameters are represented in Table 1 by tail length, 
DNA percentage in the tail, and tail moment.
In Fig.  3, the seminal glucose concentration shows a 
significant positive correlation with the seminal insulin 
level (r  =  0.247; P  =  0.006), spermatozoa insulin gene 
expression (r = 0.313; P < 0.0001), spermatozoa CIDEA 
gene expression (r  =  0.358; P  <  0.0001), and percent-
age of spermatozoa nDNA fragmentation (r  =  0.319; 
P  <  0.0001) in all studied groups (n  =  120). Moreover, 
Fig.  4 shows a significant positive correlation between 
spermatozoa CIDEA gene expression and the percentage 
of sperm nDNA fragmentation (r = 0.474; P < 0.0001) in 
all studied groups (n = 120).
Discussion
To our knowledge, the present work can be considered 
the first study to investigate the possible molecular mech-
anisms by which MS can affect male fertility. In this study, 
the patients included were suffering from male infertility 
despite a normal semen analysis, endocrine profile, and 
physical examination. The only suggested risk factor of 
infertility was having MS. A possible link between infer-
tility and MS was also suggested by Juárez-Bengoa et al. 
[28], as they found a high prevalence (61.6%) of MS in a 
studied infertile population.
In our study, subjects with MS had significantly higher 
BMI and HOMA-IR in comparison to the controls, and 
this was expected as they had criteria of MS [16]. In addi-
tion, subjects and controls had normal semen param-
eters according to WHO recommendations [1]. However, 
there were significant decreases in progressive motility, 
sperm vitality, and normal morphology in the infertile 
MS group, in comparison with the fertile MS and control 
groups. Also, there was a significant decrease in vitality 
only in the fertile MS group in comparison with the con-
trol group. These results are in agreement with those of 
Leisegang et al. [6, 29] and Bhattacharya et al. [30]. More-
over, Agbaje et al. [11] reported nearly similar results but 
with no significant differences in any of the conventional 
sperm parameters and they concluded that the signifi-
cant differences could be at the ‘molecular’ and not ‘cel-
lular’ level. In addition, MacDonald et al. [31] found no 
relationship between obese/overweight status and semen 
parameters. As obesity is a fundamental constituent of 
MS, it was theorized that some of the significant findings 
in the obesity studies might be related to the underlying 
metabolic pathophysiology associated with MS [29].
On the other hand, several studies documented that 
obese/overweight status might result in hypogonadism; 
increased scrotal temperatures; direct negative effects on 
spermatogenesis, sperm functions, and sperm count; and 
increased sperm nDNA damage [5, 6, 32–34]. Regarding 
insulin resistance, significant decreases in the semen vol-
ume, total sperm count, percent motility, percent of rapid 
progressive motility, and percent normal morphology were 
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found in diabetic males [30]. However, the values of these 
parameters were still within the normal ranges accord-
ing to WHO criteria [1]. In addition, it was reported that 
dyslipidemia, as a component of MS, was associated with 
sperm abnormalities and might lead to the development of 
male infertility [4, 35, 36]. Finally, it was found that there 
was an inverse relationship between blood pressure and 
total serum testosterone concentrations, which might 
result in impaired reproductive potential [37].
In the current study, seminal insulin and spermato-
zoal insulin gene expression were significantly higher in 
the MS groups in comparison with the control group. In 
addition, they were significantly higher in the infertile 
Table 1 General, seminal and molecular parameters in the studied subjects
SD standard deviation, P calculated probability
P significant if <0.05
a Significant relative to control group
b Significant relative to fertile-metabolic syndrome group
Control (n = 45) Fertile metabolic syndrome 
(n = 38)





 Age (years) 39.29 ± 8.52 40.01 ± 8.22 42.59 ± 7.47 0.17
 BMI 23.64 ± 2.79 34.7 ± 8.1a 35.82 ± 4.37a <0.001
 HOMA-IR 1.70 ± 0.31 4.18 ± 0.90a 4.31 ± 0.95a <0.001
Seminal parameters
 Volume (ml) 2.18 ± 0.54 2.37 ± 0.67 2.29 ± 0.56 0.33
 Sperm concentration (106/ml) 39.45 ± 14.20 37.78 ± 9.91 34.73 ± 9.69 0.19
 Progressive motility; A + B (%) 49.67 ± 14.66 43.68 ± 11.24 32.05 ± 8.69ab <0.001
 Vitality (%) 68.70 ± 22.04 54.73 ± 16.14a 36.00 ± 8.45ab <0.001
 Normal morphology (%) 23.53 ± 6.78 22.44 ± 5.02 16.08 ± 4.29ab <0.001
 Seminal glucose (mg/dl) 33.39 ± 7.49 36.5 ± 6.68 41.73 ± 11.35ab <0.001
 Seminal insulin (μIU/L) 193.72 ± 52.91 302.28 ± 70.16a 477.83 ± 90.60ab <0.001
Molecular parameters
 Insulin/β actin gene expression 0.94 ± 0.24 1.23 ± 0.25a 1.88 ± 0.63ab <0.001
 CIDEA/β actin gene expression 1.0 ± 0.01 1.44 ± 0.07a 2.47 ± 0.12ab <0.001
 DNA fragmentation (%) 20.78 ± 7.15 26.95 ± 9.43a 35.09 ± 12.50ab <0.001
 Tail length (μm) 0.76 ± 0.17 1.86 ± 0.42a 3.68 ± 0.76ab <0.001
 DNA percentage in tail (%) 6.37 ± 1.39 8.61 ± 2.64a 18.76 ± 3.72ab <0.001
 Tail Moment (TM) 1.11 ± 0.29 3.38 ± 0.98a 5.25 ± 1.25ab <0.001
Fig. 1 Agarose gel showing the RT-PCR product of gene expression 
of CIDEA gene in all of the studied groups and histogram represent-
ing the different gene expression values
 M  1     2    3   4    5   6   7    8
Insulin(261bp) 
B actin(218 bp) 
Fig. 2 Agarose gel showing the RT-PCR product of gene expression 
of spermatozoal insulin gene in all of the studied groups. A repre-
sentative photograph is shown for two control samples (lanes 5, 6), 
three fertile metabolic syndrome samples (lanes 4, 7 and 8) and three 
infertile metabolic syndrome samples (1, 2 and 3). M corresponds to 
DNA ladder (100 bp)
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MS group in comparison with the fertile MS group. 
Furthermore, seminal glucose was significantly higher 
in the infertile MS group in comparison with the fertile 
MS group and the control group. Seminal glucose con-
centration also showed a significant positive correlation 
with seminal insulin level and spermatozoa insulin gene 
expression. These results are supported by the work of 
Leisegang et  al. [6]. They found increased serum and 
seminal insulin levels, with a positive correlation between 
them, in obese individuals. Also, Alves et al. [38] reported 
that the semen of diabetic men had higher fructose and 
glucose levels.
Insulin freely crosses the blood-testis barrier (BTB) 
[39] and can be secreted by the seminal vesicles [40]. Ser-
toli cells (SCs) also express, synthesize, and secrete insu-
lin within the testes [41]. All of these mechanisms can 
explain the presence of seminal insulin in MS subjects. 
In addition, insulin is demonstrated to be synthesized 
by ejaculated spermatozoa with autocrine regulatory 
functions [20, 42]. In MS, insulin resistance in SCs may 
hypothetically be associated with a decrease in sper-
matogenesis. As increased seminal insulin is associated 
with insulin resistance and abdominal obesity, increased 
insulin exposure during spermatogenesis may potentially 
develop insulin resistance in the SCs and within the sper-
matozoa themselves. Evidence to support this hypoth-
esis may be found in the intracellular molecular cascades 
associated with insulin receptor stimulation in these cells 
[6]. Insulin exerts its effect on spermatozoa via the PI3K/
Akt intracelleular signaling pathway, leading to protein 
kinase B (PKB) phosphorylation, which may mediate 
beneficial effects on ejaculated spermatozoa [42].
In human tissues, this intracellular pathway is nega-
tively influenced in insulin resistance. Hypothetically, 
over the spermatogenic cycle, it is conceivable that sper-
matozoa may develop insulin resistance in a manner sim-
ilar to other tissue cells via a breakdown of the PI3K/Akt 
intracellular signaling pathway. This hypothesis would 
provide an explanation as to the potential negative asso-
ciation between increased seminal insulin and reduced 
Fig. 3 Correlations between seminal glucose concentration and seminal insulin level, spermatozoa insulin gene and CIDEA gene expressions as 
well as spermatozoa DNA fragmentation in all studied groups (n = 120). r Pearson correlation coefficient, P calculated probability
Fig. 4 Correlation between spermatozoa CIDEA gene expression and 
spermatozoa DNA fragmentation in all studied groups (n = 120). r 
Pearson correlation coefficient, P calculated probability
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motility of ejaculated sperm [6]. Reactive oxygen species 
(ROS) production stimulated by increased glucose may 
have a role in the pathogenesis of insulin resistance [38].
The autocrine synthesis of insulin by ejaculated sper-
matozoa with subsequent increase in seminal insulin 
can be considered as a feedback or defense mechanism 
against accumulated unutilized seminal glucose, lead-
ing to the increase in seminal insulin and glucose levels. 
This can clarify the positive correlation between seminal 
glucose and seminal insulin levels, and the significant 
increase in spermatozoa insulin gene expression in the 
infertile MS group with a significant positive correlation 
with seminal glucose.
In the present study, spermatozoa nDNA fragmen-
tation and CIDEA gene expression were significantly 
higher in infertile MS patients than in fertile MS patients, 
and both were significantly higher than the control 
group. In addition, qualitative assessment of the degree of 
DNA fragmentation shows similar results represented by 
tail length, DNA percentage in the tail, and tail moment. 
Moreover, seminal glucose concentration showed a sig-
nificant positive correlation with spermatozoa CIDEA 
gene expression and the percentage of spermatozoa 
nDNA fragmentation. Also, a significant positive corre-
lation between spermatozoa CIDEA gene expression and 
percentage of sperm nDNA fragmentation was detected. 
This is in agreement with Leisegang and colleagues [29], 
who found significantly higher percentages of spermato-
zoa with disturbed mitochondrial membrane potential 
and DNA damage in MS patients. Obesity, hyperglyce-
mia, and dyslipidemia were reported to induce oxidative 
stress state in the testicular microenvironment leading to 
increase production of ROS [4, 6, 30, 43–46]. As human 
spermatozoa are highly sensitive to oxidative stress, 
sperm plasma membrane damage and nuclear or mito-
chondrial DNA fragmentation can occur in response to 
ROS [47]. Significant DNA fragmentation can present in 
normozoospermic subfertile men, so it may be an impor-
tant mechanism of MS associated subfertility [48]. In 
addition to increased spermatozoa ROS production in 
MS, decreased ATP synthesis [49] and systemic inflam-
mation [50–52] can contribute of increased sperm nDNA 
fragmentation in MS.
Increased spermatozoa CIDEA gene expression in our 
study appeared to be a sequence of sperm plasma mem-
brane fatty acids oxidation. It was reported that patients 
with high fatty acids oxidation ability showed a higher 
CIDEA mRNA gene expression. CIDEA is important for 
the regulation of lipolysis, and disturbance in its expres-
sion may be responsible for metabolic complications of 
MS [15]. They also, reported that transient overexpres-
sion of CIDEA gene is associated with increased oxida-
tion of fatty acids and diminished oxidation of glucose. 
They observed in their study that glucose oxidation is 
40% decreased in response to the in the enhanced CIDEA 
expression [15]. It may be induced as a defense mecha-
nism to protect against energy depletion in the spermato-
zoa of MS patients [53, 54]. As both DNA fragmentation 
and CIDEA gene expression could be due to the same 
causes and happen in the same circumstances, a positive 
correlation between them appears reasonable, and both of 
them could be reliable markers for sperm functions and 
spermatozoa oxidative stress states. In addition, there 
were positive correlations between seminal glucose and 
DNA fragmentation, as well as CIDEA gene expression, 
in all the studied groups’ subjects collectively. Increased 
sperm DNA damage was reported in diabetic men due to 
high oxidative stress as a direct consequence of increased 
glycolytic capacity, induced by higher glucose availability 
in semen [38]. Amplified oxidative stress and higher DNA 
fragmentation are interconnected with apoptosis [55], 
which has been reported to be increased in spermatozoa 
from type 1 diabetes mellitus and type 2 diabetes mellitus 
patients [56].
Hyperglycemia and increased seminal glucose levels 
accelerate the accumulation of advanced glycation end 
products (AGEs), e.g. carboxymethyllysine, which are 
capable of producing, promoting, and/or intensifying oxi-
dative stress and induction of sperm nDNA damage [57]. 
The detection of high levels of advanced glycation end 
products (AGEs) and their receptors (RAGEs) through-
out the male reproductive tract, coupled with changes 
in testicular metabolite levels and spermatogenic gene 
expression, suggested that glycation might play an inte-
gral role in oxidative stress, which in turn damages sperm 
DNA [11, 58].
There are some limitations to the present study. The 
most important limitation is the lack of objective data 
supporting the proposed pathophysiology pathway of 
spermatozoal DNA fragmentation in the studied sub-
jects, as data on ROS levels for the studied subgroups 
was lacking. We recommend repeating this study to find 
a correlation between spermatozoal DNA fragmentation 
and seminal ROS levels. The small number of included 
subjects was another limitation. So, it is recommended to 
repeat this study with a larger number of subjects, to con-
firm or disconfirm its findings. In addition, further inves-
tigations are needed for comparison, interpretation, and 
defining the demarcating step at which MS can actually 
be considered as an etiologic factor for male infertility.
Conclusions
It could be concluded that MS may play a pivotal role in 
affecting male fertility potential at the molecular level, 
through its possible inducing effect on the pro-apop-
totic genes like the CIDEA gene. The role of CIDEA is 
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mediated through its effect on spermatozoa nDNA frag-
mentation as well as insulin gene expression, which can-
not be detected by the conventional computer-assisted 
semen analysis techniques. Moreover, the results of 
this study point to a new spermatozoa stress condition: 
spermatozoa insulin resistance state as a part of insulin 
resistance syndrome (MS). Spermatozoa insulin resist-
ance state is manifested by increased spermatozoa insu-
lin gene expression, as well as increased seminal plasma 
insulin and glucose levels. Consequently, MS can be con-
sidered as a stress factor that affects spermatozoa through 
increased seminal plasma insulin and glucose levels.
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